FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2193356899> ?p ?o ?g. }

• W2193356899 endingPage "1779" @default.
• W2193356899 startingPage "1779" @default.
• W2193356899 abstract "Hypercalcemia of malignancy affects up to one in five cancer patients during the course of their disease. It is associated with both liquid malignancies, commonly multiple myeloma, leukemia, and non-Hodgkins lymphoma and solid cancers, particularly breast and renal carcinomas as well as squamous cell carcinomas of any organ. The clinical manifestations of hypercalcemia are generally constitutional in nature and not specific to the inciting malignancy. Such physical manifestations can range from malaise to lethargy and confusion. Constipation and anorexia are common. Acute kidney injury is likely the most frequently encountered manifestation of end organ damage. Symptomatology is closely linked to both the absolute elevation of serum calcium levels and the rapidity of calcium rise. The majority of cases are humoral in etiology and related to parathyroid hormone-related protein (PTHrP). Approximately 20% of cases are the result of direct bone metastasis with extra-renal 1,25-dihydroxyvitamin D (calcitriol) and ectopic parathyroid hormone production likely accounting for less than 1% of cases. The diagnosis of hypercalcemia of malignancy is confirmed either by an elevated PTHrP or by an evidence of bone metastasis in the appropriate clinical setting. Treatment is predicated on the patient's symptoms and absolute serum calcium level. Interventions are aimed at lowering the serum calcium concentration by inhibiting bone resorption and increasing urinary calcium excretion, the former accomplished via bisphosphonate therapy and the latter with aggressive hydration. Novel therapies for refractory disease include denosumab, a monoclonal antibody against the receptor activator of nuclear factor κB ligand, and the calcimimetic cinacalcet. Finally, anti-PTHrP antibodies have been successfully deployed in animal models of disease. Despite the efficacy of the above therapies, hypercalcemia of malignancy portends an ominous prognosis, indicating advanced and often refractory cancer with survival on the order of months." @default.
• W2193356899 created "2016-06-24" @default.
• W2193356899 creator A5031860804 @default.
• W2193356899 creator A5059248910 @default.
• W2193356899 date "2015-12-01" @default.
• W2193356899 modified "2023-09-30" @default.
• W2193356899 title "Hypercalcemia of malignancy and new treatment options" @default.
• W2193356899 cites W1517245946 @default.
• W2193356899 cites W1588691782 @default.
• W2193356899 cites W1757679215 @default.
• W2193356899 cites W1944006306 @default.
• W2193356899 cites W1951349736 @default.
• W2193356899 cites W1965963242 @default.
• W2193356899 cites W1966434911 @default.
• W2193356899 cites W1968949906 @default.
• W2193356899 cites W1969514516 @default.
• W2193356899 cites W1972544033 @default.
• W2193356899 cites W1975492526 @default.
• W2193356899 cites W1975730940 @default.
• W2193356899 cites W1985308763 @default.
• W2193356899 cites W1985365554 @default.
• W2193356899 cites W1988780177 @default.
• W2193356899 cites W1989948051 @default.
• W2193356899 cites W1990962859 @default.
• W2193356899 cites W1998354821 @default.
• W2193356899 cites W2006825597 @default.
• W2193356899 cites W2007130920 @default.
• W2193356899 cites W2009590246 @default.
• W2193356899 cites W2013391516 @default.
• W2193356899 cites W2016909637 @default.
• W2193356899 cites W2017845136 @default.
• W2193356899 cites W2033691415 @default.
• W2193356899 cites W2035781248 @default.
• W2193356899 cites W2037935981 @default.
• W2193356899 cites W2038888549 @default.
• W2193356899 cites W2058748201 @default.
• W2193356899 cites W2059004164 @default.
• W2193356899 cites W2063309454 @default.
• W2193356899 cites W2063699543 @default.
• W2193356899 cites W2067602259 @default.
• W2193356899 cites W2068328531 @default.
• W2193356899 cites W2069146453 @default.
• W2193356899 cites W2070636400 @default.
• W2193356899 cites W2070927294 @default.
• W2193356899 cites W2073730672 @default.
• W2193356899 cites W2074858007 @default.
• W2193356899 cites W2074890088 @default.
• W2193356899 cites W2079701729 @default.
• W2193356899 cites W2079923597 @default.
• W2193356899 cites W2091244756 @default.
• W2193356899 cites W2092562224 @default.
• W2193356899 cites W2102969047 @default.
• W2193356899 cites W2104108916 @default.
• W2193356899 cites W2104298626 @default.
• W2193356899 cites W2104643140 @default.
• W2193356899 cites W2105060540 @default.
• W2193356899 cites W2105077217 @default.
• W2193356899 cites W2116016420 @default.
• W2193356899 cites W2123722113 @default.
• W2193356899 cites W2135507916 @default.
• W2193356899 cites W2137194796 @default.
• W2193356899 cites W2145949546 @default.
• W2193356899 cites W2148128295 @default.
• W2193356899 cites W2153531021 @default.
• W2193356899 cites W2154102227 @default.
• W2193356899 cites W2154756260 @default.
• W2193356899 cites W2160088903 @default.
• W2193356899 cites W2165326697 @default.
• W2193356899 cites W2168689724 @default.
• W2193356899 cites W2265091398 @default.
• W2193356899 cites W2266457946 @default.
• W2193356899 cites W2275448598 @default.
• W2193356899 cites W2323575595 @default.
• W2193356899 cites W2338457593 @default.
• W2193356899 cites W2340491629 @default.
• W2193356899 cites W2410897130 @default.
• W2193356899 cites W30364595 @default.
• W2193356899 cites W4237972581 @default.
• W2193356899 cites W4256653765 @default.
• W2193356899 doi "https://doi.org/10.2147/tcrm.s83681" @default.
• W2193356899 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4675637" @default.
• W2193356899 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26675713" @default.
• W2193356899 hasPublicationYear "2015" @default.
• W2193356899 type Work @default.
• W2193356899 sameAs 2193356899 @default.
• W2193356899 citedByCount "67" @default.
• W2193356899 countsByYear W21933568992016 @default.
• W2193356899 countsByYear W21933568992017 @default.
• W2193356899 countsByYear W21933568992018 @default.
• W2193356899 countsByYear W21933568992019 @default.
• W2193356899 countsByYear W21933568992020 @default.
• W2193356899 countsByYear W21933568992021 @default.
• W2193356899 countsByYear W21933568992022 @default.
• W2193356899 countsByYear W21933568992023 @default.
• W2193356899 crossrefType "journal-article" @default.
• W2193356899 hasAuthorship W2193356899A5031860804 @default.
• W2193356899 hasAuthorship W2193356899A5059248910 @default.
• W2193356899 hasBestOaLocation W21933568991 @default.

• next